1. The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis
    Shin Ishikane et al, 2018, Biochemical Pharmacology CrossRef
  2. Animal models of cholangiocarcinoma
    Emilien Loeuillard et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  3. Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux
    Mohammad Rasheduzzaman et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  4. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein
    Soichiro Saikawa et al, 2018, Cancer Letters CrossRef
  5. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
    Alessandra Gentilini et al, 2018, IJMS CrossRef
  6. Beyond the boundaries of cardiology: still untapped anticancer properties of the cardiovascular system-related drugs
    Katarzyna Regulska et al, 2019, Pharmacological Research CrossRef
  7. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma
    Zai-Fa Hong et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  8. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis
    Junjie Kong et al, 2020, CBM CrossRef
  9. Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells
    Anna M. Schoepf et al, 2020, European Journal of Medicinal Chemistry CrossRef
  10. Evolution of the Experimental Models of Cholangiocarcinoma
    Annamaria Massa et al, 2020, Cancers CrossRef
  11. Elucidating the Association Between the Upregulation of Angiotensin Type 1-Receptors and the Development of Gastrointestinal Malignancies
    Mohammad-Hassan Arjmand, 2020, J Gastrointest Canc CrossRef
  12. Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation.
    Yan Wang et al, 2022, Asia Pac J Clin Oncol CrossRef
  13. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
    José A. Carlos-Escalante et al, 2021, Front. Oncol. CrossRef
  14. Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma
    Jingcheng Hao et al, 2021, Oncol Rep CrossRef
  15. Telmisartan anti‐cancer activities mechanism through targeting N‐cadherin by mimicking ADH‐1 function
    Marjan Khorsand et al, 2022, J Cellular Molecular Medi CrossRef
  16. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
    Richard E. Kast et al, 2022, Cancers CrossRef
  17. Adverse effects of SYP-3343 on zebrafish development via ROS-mediated mitochondrial dysfunction
    Guoliang Chen et al, 2022, Journal of Hazardous Materials CrossRef
  18. Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis
    Rie HASHIMOTO et al, 2022, J Nutr Sci Vitaminol CrossRef
  19. Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
    Thidarath Rattanaburee et al, 2022, Molecules CrossRef
  20. ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway
    Lingying Zhang et al, 2022, Med Oncol CrossRef
  21. Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis
    Zexu Wang et al, 2023, JPM CrossRef
  22. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
    Diego F. Calvisi et al, 2023, Nat Rev Gastroenterol Hepatol CrossRef
  23. In Vitro Drug Repurposing: Focus on Vasodilators
    Eduarda Ribeiro et al, 2023, Cells CrossRef
  24. Adverse Effects of SYP-3343 on Zebrafish Development Via ROS-Mediated Mitochondrial Dysfunction
    Guoliang Chen et al, 2021, SSRN Journal CrossRef
  25. Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy
    Valerie Gunchick et al, 2023 CrossRef
  26. Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
    Mohamad Ali Hijazi et al, 2023, Cancers CrossRef
  27. Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study
    Xiao-Xu Zhu et al, 2023, BMC Cancer CrossRef
  28. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
    Takanori Matsui et al, 2019, Int J Mol Sci CrossRef